FDA recall D-0065-2026

GenoGenix LLC · Class II · drug

Product

NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health

Reason for recall

Lack of Assurance of Sterility

Distribution

US Nationwide.

Key facts

Status: Ongoing
Initiation date: 2025-07-30
Report date: 2025-10-15
Voluntary/Mandated: Voluntary: Firm initiated
Location: Boca Raton, FL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0065-2026